Zobrazeno 1 - 6
of 6
pro vyhledávání: '"D. A. Rhein"'
Autor:
Leonie I. Kroeze, M. van den Heuvel, D. von Rhein, Katrien Grünberg, R. M. de Voer, Erik A. M. Jansen, M.J.L. Ligtenberg, G. Van den Heuvel
Publikováno v:
Annals of Oncology. 31:S1217-S1218
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::beb2fe70a035c5918a3f5f681f23068f
https://doi.org/10.1016/j.annonc.2020.08.2162
https://doi.org/10.1016/j.annonc.2020.08.2162
Publikováno v:
The Journal of Immunology. 159:4930-4934
Theiler's murine encephalomyelitis virus (TMEV)-induced demyelination and experimental allergic encephalomyelitis are the principal immunologically mediated, genetically controlled models of multiple sclerosis. Previous studies using different mappin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d74e1961024b0df5fb918ebe29c8611
https://doi.org/10.4049/jimmunol.159.10.4930
https://doi.org/10.4049/jimmunol.159.10.4930
Autor:
M L, Curtin, S K, Davidsen, H R, Heyman, R B, Garland, G S, Sheppard, A S, Florjancic, L, Xu, G M, Carrera, D H, Steinman, J A, Trautmann, D H, Albert, T J, Magoc, P, Tapang, D A, Rhein, R G, Conway, G, Luo, J F, Denissen, K C, Marsh, D W, Morgan, J B, Summers
Publikováno v:
Journal of medicinal chemistry. 41(1)
Studies conducted with the goal of discovering a second-generation platelet-activating factor (PAF) antagonist have identified a novel class of potent and orally active antagonists which have high aqueous solubility and long duration of action in ani
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3bb2c074df0fa0c2bbeaf883649b3410
https://pubmed.ncbi.nlm.nih.gov/9438024
https://pubmed.ncbi.nlm.nih.gov/9438024
Autor:
C, Teuscher, D M, Rhein, K D, Livingstone, R A, Paynter, R W, Doerge, S M, Nicholson, R W, Melvold
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 159(10)
Theiler's murine encephalomyelitis virus (TMEV)-induced demyelination and experimental allergic encephalomyelitis are the principal immunologically mediated, genetically controlled models of multiple sclerosis. Previous studies using different mappin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9052f49d958b6b4d5a545b6200945e92
https://pubmed.ncbi.nlm.nih.gov/9366418
https://pubmed.ncbi.nlm.nih.gov/9366418
Autor:
D H, Albert, R G, Conway, T J, Magoc, P, Tapang, D A, Rhein, G, Luo, J H, Holms, S K, Davidsen, J B, Summers, G W, Carter
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 277(3)
ABT-299 is an aqueous soluble prodrug that is converted rapidly in vivo to A-85783, a novel, highly potent, specific platelet activating factor (PAF) antagonist. The K, for inhibiting PAF binding to rabbit platelet membranes is 3.9 and 0.3 nM for hum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4fca4b574a066c2950a9819ae31000eb
https://pubmed.ncbi.nlm.nih.gov/8667228
https://pubmed.ncbi.nlm.nih.gov/8667228
Publikováno v:
Journal of Clinical Oncology. 22:6068-6068
6068 Background: One purpose of PIs is to provide prescribers' with relevant safety information to make therapeutic decisions. We conducted a review of PIs for anti-cancer agents approved between 1...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f8cc21dd5e76414100ea4de8c2d65cf
https://doi.org/10.1200/jco.2004.22.90140.6068
https://doi.org/10.1200/jco.2004.22.90140.6068